Published in Eur J Biochem on September 01, 1979
Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol (2009) 1.58
Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal orphan receptor response element and a distant enhancer located in the upstream promoter region of the apolipoprotein C-III gene. Nucleic Acids Res (1994) 1.17
Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest (1997) 1.03
Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph. J Clin Invest (1985) 0.93
Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J Clin Invest (1994) 0.92
Genetic studies of human apolipoproteins. I. Polymorphism of apolipoprotein A-IV. Am J Hum Genet (1987) 0.92
Apolipoprotein A-IV: a protein intimately involved in metabolism. J Lipid Res (2015) 0.88
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT. J Lipid Res (2012) 0.82
Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet (1992) 0.82
ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety. Am J Physiol Gastrointest Liver Physiol (2015) 0.79
Plasma lipoprotein and apolipoprotein distribution as a function of density in the rainbow trout (Salmo gairdneri). Biochem J (1987) 0.77
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry. PLoS One (2016) 0.75
Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein. J Clin Invest (1993) 0.75
A genome-wide association meta-analysis on apolipoprotein A-IV concentrations. Hum Mol Genet (2016) 0.75
Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria. Pediatr Nephrol (2017) 0.75
Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J Biol Chem (1981) 3.54
Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem (1982) 3.22
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med (1990) 3.17
Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation (1999) 3.08
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature (1977) 3.04
Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (1991) 2.87
Surface distribution and recycling of the low density lipoprotein receptor as visualized with antireceptor antibodies. J Cell Biol (1982) 2.84
Studies on the amphipathic nature of the membrane proteins in Semliki Forest virus. J Mol Biol (1974) 2.37
Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest (1987) 2.35
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
mtDNA analysis of Nile River Valley populations: A genetic corridor or a barrier to migration? Am J Hum Genet (1999) 2.25
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22
Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet (1979) 2.14
Immunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia. J Biol Chem (1982) 2.13
Lipoprotein(a): resurrected by genetics. J Intern Med (2012) 2.12
Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) Circulation (1995) 2.01
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res (1982) 2.01
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest (1989) 1.92
The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet (1991) 1.88
Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett (1975) 1.87
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol (1996) 1.86
Apolipoprotein E polymorphism in health and disease. Am Heart J (1987) 1.84
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest (1981) 1.79
Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet (1988) 1.68
Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet (1979) 1.66
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis (1989) 1.64
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61
Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet (1991) 1.59
Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res (2001) 1.51
Lipoprotein(a) in renal disease. Am J Kidney Dis (1996) 1.51
Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry (1990) 1.51
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia (1993) 1.42
Immunologic cross-reactivity of the low density lipoprotein receptor from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver. J Biol Chem (1981) 1.41
Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E. Hoppe Seylers Z Physiol Chem (1975) 1.39
Unequal crossing-over between two alu-repetitive DNA sequences in the low-density-lipoprotein-receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolaemia. Eur J Biochem (1987) 1.34
Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet (1989) 1.34
Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett (1983) 1.32
Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem (1985) 1.27
Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet (1984) 1.26
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet (1992) 1.26
Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein. J Biol Chem (1983) 1.26
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. J Biol Chem (1993) 1.22
Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol (1996) 1.20
An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur J Biochem (1979) 1.18
Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb (1992) 1.17
A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res (1987) 1.15
Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem (1990) 1.14
Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis. Hum Genet (1982) 1.14
Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab Invest (1997) 1.12
Sensorineural hearing loss and the incidence of Cx26 mutations in Austria. Eur J Hum Genet (2001) 1.10
Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo. J Biol Chem (2001) 1.10
Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations. Eur J Hum Genet (2001) 1.09
Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur J Immunol (1999) 1.09
Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J Med Genet (2004) 1.07
Lipoprotein(a) in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2000) 1.07
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis (2000) 1.06
Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic Biol Med (2001) 1.06
Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group. Clin Chem Lab Med (2000) 1.04
T cell expressed PKCtheta demonstrates cell-type selective function. Eur J Immunol (2000) 1.04
The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins. J Biol Chem (1997) 1.04
Different mobility in SDS--polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes apo E-N and Apo E-D. FEBS Lett (1979) 1.04
The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum Mol Genet (1993) 1.03
Variation in the size of human apolipoprotein(a) is due to a hypervariable region in the gene. Hum Genet (1990) 1.02
Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest (1992) 1.01
Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries. Virchows Arch A Pathol Anat Histopathol (1990) 1.01
Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res (1994) 1.01
Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A (1993) 1.01
Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia. Metabolism (1981) 1.01
Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum Mol Genet (2001) 1.00
Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet (1996) 1.00
Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (1995) 0.99
A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest (1995) 0.99
Detection of a de novo duplication of 1q32-qter by fluorescence in situ hybridisation in a boy with multiple malformations: further delineation of the trisomy 1q syndrome. J Med Genet (1997) 0.99
Increased lipoprotein oxidation in Alzheimer's disease. Free Radic Biol Med (2000) 0.99
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet (1998) 0.99
Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet (1986) 0.98
Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis. J Lipid Res (1984) 0.97
The gene for the Lp(a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6. Hum Genet (1989) 0.97
Studies on the metabolic defect in Broad-beta disease (hyperlipoproteinaemia type III). Clin Genet (1977) 0.96
Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet (1984) 0.96
Mutations in the human DHCR7 gene. Hum Mutat (2001) 0.96
Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation. Clin Genet (1978) 0.96
Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur J Hum Genet (1999) 0.96
Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI. Hum Genet (1982) 0.96
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations. J Med Genet (2007) 0.96
Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment. J Biol Chem (2000) 0.96
Cloning, structural analysis, and chromosomal localization of the human CSRP2 gene encoding the LIM domain protein CRP2. Genomics (1997) 0.96
Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis (1999) 0.96
Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest (1991) 0.96
The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem (1996) 0.96
Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation. J Biol Chem (1982) 0.95
The membrane proteins of Semliki Forest virus have a hydrophobic part attached to the viral membrane. FEBS Lett (1972) 0.95
Whole genome amplification from microdissected chromosomes. Cytogenet Genome Res (2009) 0.95